Formic Acid

Formic Acid

SCHEMBL4398916

CNc1ccc(CC(=O)Nc2ccc(SC(F)F)cc2)cc1.O=CO

nearest known ligand 0.69

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.69
MAPT P10636 5/20 0.69
KMT2A Q03164 5/20 0.69
SMN1; SMN2 Q16637 7/20 0.68
LMNA P02545 5/20 0.68
GAA P10253 5/20 0.68
RAB9A P51151 4/20 0.68
NPC1 O15118 3/20 0.68
HTT P42858 2/20 0.61
L3MBTL1 Q9Y468 1/20 0.61
MAP4K4 O95819 1/20 0.57
ABL1 P00519 1/20 0.57
NTRK1 P04629 1/20 0.57
LCK P06239 1/20 0.57
FYN P06241 1/20 0.57
CSF1R P07333 1/20 0.57
RET P07949 1/20 0.57
IGF1R P08069 1/20 0.57
PDGFRB P09619 1/20 0.57
FGFR1 P11362 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2284438 0.95 MEN1 (0.76) MEN1MAPTKMT2ASMN1; SMN2LMNA
SCHEMBL15520341 0.83 SMN1; SMN2 (0.82) MEN1MAPTKMT2ASMN1; SMN2LMNA
SCHEMBL2287139 0.82 MEN1 (0.76) MEN1MAPTKMT2ASMN1; SMN2LMNA
SCHEMBL2284674 0.81 MAPT (0.70) MEN1MAPTKMT2ASMN1; SMN2LMNA
SCHEMBL2285752 0.80 KMT2A (0.69) MEN1MAPTKMT2ASMN1; SMN2LMNA
SCHEMBL2287803 0.79 MEN1 (0.67) MEN1MAPTKMT2ASMN1; SMN2LMNA
SCHEMBL2286256 0.79 MAPT (0.67) MEN1MAPTKMT2ASMN1; SMN2LMNA
SCHEMBL2281683 0.78 MEN1 (0.66) MEN1MAPTKMT2ASMN1; SMN2LMNA
SCHEMBL2285379 0.78 MEN1 (0.69) MEN1MAPTKMT2ASMN1; SMN2LMNA
SCHEMBL2289004 0.77 MEN1 (0.65) MEN1MAPTKMT2ASMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009145996-A2 AMIDE DERIVATIVES AS POSITIVE ALLOSTERIC MODULATORS AND METHODS OF USE THEREOF ABBOTT LABORATORIES (US) 2009-12-03 WO disclosed